Delivery Order SPE2DB22D2007-SPE2DB25FJ3RV
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for the supply of Dupixent 300 mg/2 ml syringes (2 ml configuration) valued at $5,768.54. The contract is a firm fixed price delivery order awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, and carries no set-aside designation. This award represents a single transaction under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp has been awarded a $92,175.01 delivery order by the Defense Logistics Agency (DLA) for Dupixent 300 mg/2 mL pens, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $86,474.81 for Dupixent 300mg/2mL (2 units) under a firm fixed price contract with the Defense Logistics Agency Medical Supply Chain. The award was made on August 22, 2025, with an ultimate completion date of September 19, 2025. This non-set-aside, competitively awarded delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of...
- Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide Dupixent 300 mg/2 ml syringes. The contract has a potential value of $7,666.89 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not associated with any set-aside designation. The company also holds an indefinite delivery contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,770.06 by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 12, 2025. The pharmaceutical will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and distribution hub for federal...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,951.37 firm fixed price delivery order is for Dupixent 300 mg/2 ml syringes, a specialty pharmaceutical product. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,302.48 on July 25, 2025, for the supply of Dupixent 300 mg/2 ml syringes. The contract is competitively awarded with no set-aside designation and carries an ultimate completion date of July 28, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $7,193.82 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside delivery order with performance to be completed by July 31, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency has awarded a delivery order valued at $20,513.52 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. The contract is non-competitive, firm fixed price, and scheduled for completion by September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,970.25 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery transaction under AmerisourceBergen's existing pharmaceutical supply framework. The place of performance is listed as Conshohocken, Pennsylvania, where...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3RVDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $19,042.85 to supply Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 6, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its role as a critical pharmaceutical distributor for Department of Defense medical supply chains. The parent IDC encompasses a broad range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialty therapeutics across multiple therapeutic domains. This delivery order represents one of numerous competitive awards under the larger contract vehicle, reflecting the company's capability to meet federal procurement requirements and support military healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.0k | 8/5/25 |